Serum institute of india pvt. ltd, Company

EU Ambassador to India Ugo Astuto has clarified that there is no ban in the European Union on Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.Astuto toldin an interview that Pune-based SII has apparently not yet applied to European Medicines Agency (EMA) with a request for approval of the COVID-19 vaccine.Asked why 'Vaxzervria' vaccine, also developed by AstraZeneca has been permitted in EU and not Covishield, he said every approval process must be conducted on its own merit."Obviously these are medical sensitivities, medical experts will be better placed to respond. Every approval process of vaccine must be conducted on its own merit. No matter how close the process is, it is because vaccines are biological products so even a tiny difference in manufacturing conditions can result in differences. So each and every product needs to undergo its own scrutiny process," Astuto told ANI."Based on what I read, status from European Medicines Agency (EMA), they say they have not received a request for approval of Covishield. I'm sure when they receive they will process it based on their own internal procedures. I think EMA cannot start any procedure on its own if it hasn't received a request," he added.The EU Ambassador said that a new system has been put in place of the digital COVID certificate."It is to clarify there is no banning on Covishield. We have set up in place a new system of Digital Covid Certificate which is meant to facilitate travel within the European Union. Basically, this certificate is proof that a person is vaccinated against COVID or received a negative test or recovered from COVID-19. So this is meant as a facilitator but it is not a precondition for travel."For example, people who are not vaccinated should still be allowed to travel, subject to the usual restrictions like testing, quarantine, self-isolation measures related to COVID health policy," he said.He said that under the new digital COVID certificate system, EU member states can accept a vaccine that has received EU-wide approval from EMA, but the regulation of digital certificate also leaves open to member states the possibility of accepting vaccination certificates issued in relation to the vaccine that has been authorized by WHO."That's a relevant feature to the system," the EU Ambassador said.He also confirmed that talks at the diplomatic level are also on to resolve the issue."We always talk with our friends from the Ministry of External Affairs about all issues of common interest so this is not excluded and whenever any issue arises, together we work in a way so that outcome is satisfactory to all sides," he said.Covaxin, an indigenous COVID-19 vaccine, is also awaiting approval from the WHO for emergency use authorization.Covishield has been and is exported to many countries and until EMA gives approval, there will be issues faced by people in many countries."There is a process to be followed and again I'm not best placed to tell you. That's why we have EMA, an independent agency. I'm sure they will examine with due care any request," the EU Ambassador said.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Serum Institute Of India Pvt. LtdFOLLOW

Serum institute of india pvt. ltd, Latest News

Union Minister Mansukh Mandaviya on Friday visited a vaccine manufacturing plant of the Serum Institute of India in Pune to review the production of vaccines. ...

People often cannot choose what vaccine they get and a vaccine should not put a person at disadvantage if it is approved and is in use, Estonia Ambassador to India Katrin Kivi said on Friday. ...

Nepal on Friday said it is yet to receive a million doses of COVID-19 vaccines from India, for which the advance payment has already been done. ...

The Netherlands became the latest European Union (EU) country to approve the Serum Institute of India (SII)-manufactured Covishield vaccine for travellers, days after India pushed for the approval of its COVID-19 vaccines in Europe. ...

An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sourc ...

Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday. ...

Prabhuji Online, India's fastest growing technology enabled "Subscription Commerce Company", has raised an undisclosed amount of funds in pre-series A round from Singapore and India based marquee angel investors. ...

EU Ambassador to India Ugo Astuto has clarified that there is no ban in the European Union on Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University. ...